References
Naidech A. Improving platelet activity for cerebral hemorrhage treatment (IMPACT). Neurocrit Care. 2009;11:S17 [abstract].
Morgenstern LB, Hemphill JC 3rd, Anderson C, Becker K, Broderick JP, Connolly ES Jr, Greenberg SM, Huang JN, Macdonald RL, Messe SR, Mitchell PH, Selim M, Tamargo RJ. Guidelines for the management of spontaneous intracerebral hemorrhage. A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2010;41:2108–29.
Naidech AM, Bernstein RA, Bendok BR, Alberts MJ, Batjer HH. Response to Letter by Creutzfeldt et al. Stroke. 2009;40(11):e646.
Naidech AM, Rosenberg NF, Maas MB, Bendok BR, Batjer HH, Nemeth AJ. Predictors of hemorrhage volume and disability after perimesencephalic subarachnoid hemorrhage. Neurology. 2012;78(11):811.
Acknowledgments
AMN has received research funds from the Northwestern Memorial Foundation related to this topic.
Disclosure
Northwestern University has applied for a use patent on desmopressin for acute intracerebral hemorrhage. It is unclear what financial value, if any, this patent may have if granted.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Naidech, A.M., Liebling, S.M., Rosenberg, N.F. et al. Early Platelet Transfusion Improves Platelet Activity and May Improve Outcomes After Intracerebral Hemorrhage. Neurocrit Care 17, 156–157 (2012). https://doi.org/10.1007/s12028-012-9698-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12028-012-9698-9